Diamedica Therapeutics Stock Price on January 2, 2024
| DMAC Stock | USD 5.38 0.26 4.61% |
Below is the normalized historical share price chart for DiaMedica Therapeutics extending back to January 04, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DiaMedica Therapeutics stands at 5.38, as last reported on the 15th of December 2024, with the highest price reaching 5.66 and the lowest price hitting 5.31 during the day.
If you're considering investing in DiaMedica Stock, it is important to understand the factors that can impact its price. DiaMedica Therapeutics appears to be slightly risky, given 3 months investment horizon. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0962, which denotes the company had a 0.0962% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for DiaMedica Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize DiaMedica Therapeutics' Mean Deviation of 2.69, semi deviation of 2.34, and Downside Deviation of 2.6 to check if our risk estimates are consistent with your expectations.
At present, DiaMedica Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 56.9 M, whereas Stock Based Compensation is forecasted to decline to about 876.3 K. . As of December 15, 2024, Price To Sales Ratio is expected to decline to 49.24. In addition to that, Price Earnings Ratio is expected to decline to -5.01. DiaMedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2008 | 200 Day MA 3.5502 | 50 Day MA 4.5992 | Beta 1.456 |
DiaMedica |
Sharpe Ratio = 0.0962
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DMAC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.51 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average DiaMedica Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaMedica Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.7963 | Book Value 1.345 | Enterprise Value 180.2 M | Enterprise Value Ebitda (0.96) | Shares Float 26.3 M |
DiaMedica Therapeutics Main Headline on 2nd of January 2024
Acquisition by James Parsons of 21428 shares of DiaMedica Th... by James Parsons
Filed transaction by Diamedica Therapeutics In director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
DiaMedica Therapeutics Valuation on January 2, 2024
It is possible to determine the worth of DiaMedica Therapeutics on a given historical date. On January 2, 2024 DiaMedica was worth 2.84 at the beginning of the trading date compared to the closed value of 2.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of DiaMedica Therapeutics stock. Still, in general, we apply an absolute valuation method to find DiaMedica Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of DiaMedica Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against DiaMedica Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.93 | 2.98 | 2.82 | 2.84 | 37,096 | |
01/02/2024 | 2.84 | 2.91 | 2.77 | 2.83 | 21,242 |
| 2.77 | 2.90 | 2.77 | 2.90 | 26,758 |
| Backtest DiaMedica Therapeutics | | | DiaMedica Therapeutics History | | | DiaMedica Therapeutics Valuation | Previous | Next |
DiaMedica Therapeutics Trading Date Momentum on January 2, 2024
| On January 03 2024 DiaMedica Therapeutics was traded for 2.90 at the closing time. The top price for the day was 2.90 and the lowest listed price was 2.77 . The trading volume for the day was 26.8 K. The trading history from January 3, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 2.47% . The overall trading delta against the current closing price is 8.83% . |
DiaMedica Therapeutics Fundamentals Correlations and Trends
By evaluating DiaMedica Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among DiaMedica Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. DiaMedica financial account trend analysis is a perfect complement when working with valuation or volatility modules.About DiaMedica Therapeutics Stock history
DiaMedica Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DiaMedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DiaMedica Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DiaMedica Therapeutics stock prices may prove useful in developing a viable investing in DiaMedica Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 32.6 M | 34.2 M | |
| Net Loss | -12.2 M | -11.6 M |
DiaMedica Therapeutics Quarterly Net Working Capital |
|
DiaMedica Therapeutics Stock Technical Analysis
DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
DiaMedica Therapeutics Period Price Range
Low | December 15, 2024
| High |
0.00 | 0.00 |
DiaMedica Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
DiaMedica Therapeutics December 15, 2024 Market Strength
Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns
DiaMedica Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for DiaMedica Therapeutics' price direction in advance. Along with the technical and fundamental analysis of DiaMedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DiaMedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0909 | |||
| Jensen Alpha | 0.3781 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.1166 | |||
| Treynor Ratio | 2.33 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |